FR2254344A1 - - Google Patents
Info
- Publication number
- FR2254344A1 FR2254344A1 FR7441101A FR7441101A FR2254344A1 FR 2254344 A1 FR2254344 A1 FR 2254344A1 FR 7441101 A FR7441101 A FR 7441101A FR 7441101 A FR7441101 A FR 7441101A FR 2254344 A1 FR2254344 A1 FR 2254344A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14055673A JPS5629666B2 (OSRAM) | 1973-12-14 | 1973-12-14 | |
| JP49024999A JPS589100B2 (ja) | 1974-03-01 | 1974-03-01 | シンキナ キナゾリンジオンユウドウタイ ノ セイゾウホウ |
| JP49035325A JPS5761742B2 (OSRAM) | 1974-03-28 | 1974-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2254344A1 true FR2254344A1 (OSRAM) | 1975-07-11 |
| FR2254344B1 FR2254344B1 (OSRAM) | 1978-07-28 |
Family
ID=27284866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7441101A Expired FR2254344B1 (OSRAM) | 1973-12-14 | 1974-12-13 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4016166A (OSRAM) |
| DE (1) | DE2459090A1 (OSRAM) |
| FR (1) | FR2254344B1 (OSRAM) |
| GB (1) | GB1491510A (OSRAM) |
| NL (1) | NL7416022A (OSRAM) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5271484A (en) * | 1975-12-11 | 1977-06-14 | Hisamitsu Pharmaceut Co Inc | Synthesis of novel quinazoline derivatives |
| DE3150271A1 (de) * | 1981-12-18 | 1983-06-30 | Troponwerke GmbH & Co KG, 5000 Köln | 1-(3-nitrophenyl)pyrido(2.3-d)pyrimidin-2.4(1h, 3h)-dione und 1-(3-nitrophenyl)chinazolin-2.4(1h, 3h)-dione als cutane arzneimittel |
| DE3347526A1 (de) * | 1983-12-30 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | Verfahren zur herstellung substituierter chinazolin-2.4(1h.3h)-dione |
| DE3563964D1 (en) * | 1984-10-16 | 1988-09-01 | Synthelabo | Piperidine derivatives, their preparation and their therapeutical application |
| GB8524663D0 (en) * | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
| DE69701647T2 (de) * | 1996-02-01 | 2000-09-07 | Sumitomo Chemical Co., Ltd. | Verfahren zur Herstellung von Dioxochinazolinen |
| US7632866B2 (en) * | 2002-10-21 | 2009-12-15 | Ramot At Tel Aviv University | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CN1856310A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 喹唑啉钾通道抑制剂 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2393885T7 (es) | 2007-06-04 | 2014-01-30 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| CN101868443A (zh) | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-苯基邻氨基苯甲酸衍生物及其用途 |
| WO2009149279A2 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP3366698A1 (en) | 2011-03-01 | 2018-08-29 | Synergy Pharmaceuticals Inc. | Guanylate cyclase c agonists |
| AU2014218599C1 (en) | 2013-02-25 | 2018-09-06 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists for use in colonic cleansing |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| US20160184387A1 (en) | 2013-08-09 | 2016-06-30 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| EP3972599B1 (en) | 2019-05-21 | 2025-10-22 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1059271A (en) | 1964-02-05 | 1967-02-15 | Ici Ltd | Quinazolin-2,4-diones and pharmaceutical compositions thereof |
| NL127736C (OSRAM) | 1964-04-20 | |||
| GB1311573A (en) * | 1970-04-27 | 1973-03-28 | Hisamitsu Pharmaceutical Co | Quinazolinedione derivatives |
| US3794643A (en) * | 1971-04-20 | 1974-02-26 | Hisamitsu Pharmaceutical Co | Quinazolinedione derivatives |
| JPS505140A (OSRAM) * | 1973-05-16 | 1975-01-20 |
-
1974
- 1974-12-09 GB GB53052/74A patent/GB1491510A/en not_active Expired
- 1974-12-09 US US05/531,097 patent/US4016166A/en not_active Expired - Lifetime
- 1974-12-10 NL NL7416022A patent/NL7416022A/xx not_active Application Discontinuation
- 1974-12-13 DE DE19742459090 patent/DE2459090A1/de not_active Withdrawn
- 1974-12-13 FR FR7441101A patent/FR2254344B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4016166A (en) | 1977-04-05 |
| NL7416022A (nl) | 1975-06-17 |
| FR2254344B1 (OSRAM) | 1978-07-28 |
| DE2459090A1 (de) | 1975-06-26 |
| GB1491510A (en) | 1977-11-09 |
| AU7612574A (en) | 1976-06-10 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |